A Phase 3 Evaluation of Daclatasvir and Sofosbuvir in Subjects Co-infected with Human Immunodeficiency Virus (HIV) and Previously Untreated Genotype 1, 2, 3, 4, 5, or 6 Chronic Hepatitis C Infection